131 related articles for article (PubMed ID: 25902416)
1. Knockdown of metadherin inhibits angiogenesis in breast cancer.
Liu Y; Kong X; Li X; Li B; Yang Q
Int J Oncol; 2015; 46(6):2459-66. PubMed ID: 25902416
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference - functions as a potential tumor suppressor in breast cancer.
Wang S; Shu JZ; Cai Y; Bao Z; Liang QM
Asian Pac J Cancer Prev; 2012; 13(6):2813-8. PubMed ID: 22938464
[TBL] [Abstract][Full Text] [Related]
4. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
5. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
6. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
[TBL] [Abstract][Full Text] [Related]
7. microRNA-22 acts as a metastasis suppressor by targeting metadherin in gastric cancer.
Tang Y; Liu X; Su B; Zhang Z; Zeng X; Lei Y; Shan J; Wu Y; Tang H; Su Q
Mol Med Rep; 2015 Jan; 11(1):454-60. PubMed ID: 25323629
[TBL] [Abstract][Full Text] [Related]
8. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
[TBL] [Abstract][Full Text] [Related]
9. MiR-630 suppresses breast cancer progression by targeting metadherin.
Zhou CX; Wang CL; Yu AL; Wang QY; Zhan MN; Tang J; Gong XF; Yin QQ; He M; He JR; Chen GQ; Zhao Q
Oncotarget; 2016 Jan; 7(2):1288-99. PubMed ID: 26595523
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of metadherin sensitizes breast cancer cells to AZD6244.
Kong X; Moran MS; Zhao Y; Yang Q
Cancer Biol Ther; 2012 Jan; 13(1):43-9. PubMed ID: 22336587
[TBL] [Abstract][Full Text] [Related]
11. Metadherin regulates radioresistance in cervical cancer cells.
Zhao Y; Moran MS; Yang Q; Liu Q; Yuan C; Hong S; Kong B
Oncol Rep; 2012 May; 27(5):1520-6. PubMed ID: 22367022
[TBL] [Abstract][Full Text] [Related]
12. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
Hui AB; Bruce JP; Alajez NM; Shi W; Yue S; Perez-Ordonez B; Xu W; O'Sullivan B; Waldron J; Cummings B; Gullane P; Siu L; Liu FF
Clin Cancer Res; 2011 Dec; 17(24):7539-50. PubMed ID: 22031094
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1271 suppresses the proliferation and invasion of colorectal cancer cells by regulating metadherin/Wnt signaling.
Sun X; Zhai H; Chen X; Kong R; Zhang X
J Biochem Mol Toxicol; 2018 Feb; 32(2):. PubMed ID: 29315995
[TBL] [Abstract][Full Text] [Related]
14. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
[TBL] [Abstract][Full Text] [Related]
15. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.
Zhao Y; Kong X; Li X; Yan S; Yuan C; Hu W; Yang Q
PLoS One; 2011; 6(12):e29363. PubMed ID: 22195048
[TBL] [Abstract][Full Text] [Related]
16. MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells.
Cao D; Zhu H; Zhao Q; Huang J; Zhou C; He J; Liang Y
Biol Res; 2020 Sep; 53(1):43. PubMed ID: 32993809
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11.
Siragam V; Rutnam ZJ; Yang W; Fang L; Luo L; Yang X; Li M; Deng Z; Qian J; Peng C; Yang BB
Oncotarget; 2012 Nov; 3(11):1370-85. PubMed ID: 23211491
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer.
Flores-Pérez A; Marchat LA; Rodríguez-Cuevas S; Bautista-Piña V; Hidalgo-Miranda A; Ocampo EA; Martínez MS; Palma-Flores C; Fonseca-Sánchez MA; Astudillo-de la Vega H; Ruíz-García E; González-Barrios JA; Pérez-Plasencia C; Streber ML; López-Camarillo C
Sci Rep; 2016 Oct; 6():34504. PubMed ID: 27703260
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.
He T; Qi F; Jia L; Wang S; Song N; Guo L; Fu Y; Luo Y
J Pathol; 2014 Apr; 232(5):499-508. PubMed ID: 24403060
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
